Stocks fell sharply on Thursday as the Fed's lowered outlook and disappointing economic data rattled investors, who had been recently feeling optimistic. Initial jobless claims dropped by 12,000 to a seasonally adjusted 631,000 last week, slightly higher than expected, and continuing claims surged to another record. Experts weighed in on the above and more. Read and listen to what they had to say...
Stocks pared their gains on Wednesday as banks pulled back but investors remained hopeful that the worst may be over for the economy. Treasury Secretary Timothy Geithner told a Senate panel that financial markets are "starting to heal" and that a program to remove toxic assets from bank balance sheets would begin in the next six weeks. Read and listen to what experts had to say...
The CNBC Stock Blog is a cross-section of expert opinions and insights from our TV and Web site coverage. This blog includes posts written by and about top analysts and strategists, super-investors and CNBC's own market mavens. You'll find stock picks, news about publicly-traded companies, commodities, hot sectors, ETFs and the latest options action.
J. Michael Pearson, Valeant Pharmaceuticals chairman & CEO, explains why he decided to pursue Allergan and shares his R&D business model, with CNBC's Kate Kelly. This year we are launching 19 products in the United States, says Pearson.
Wednesday, 23 Apr 2014 | 6:13 AM ET
Chris Caso, Susquehanna Financial Group analyst, shares his outlook on Apple in the second half. Apple needs to show shareholders the next new thing, says Caso.
Wednesday, 23 Apr 2014 | 4:10 AM ET
Fraser Howie, director at Newedge Singapore, says the PMI data reveals China is "in a bit of a rut" and that the government has a "horrible problem" as it can't bring out too much stimulus.